“…HAI plus systemic chemotherapy has been associated with response rates of 60-90% for unresectable CLM, even in the second and third line settings, with conversion to resectability in up to 35% of patients [3,4,[15][16][17][18]. Critics of this approach cite a significant incidence of short-and long-term complications, including complications related to the pump itself and biliary sclerosis, which is reversible if recognized in its early stages but can lead to stricture and liver failure.…”